Actinium Pharmaceuticals, Inc.
(NYSE Amex Equities : ATNM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 2.59%60.680.0%$930.66m
NVAXNovavax, Inc. 36.12%108.13102.0%$754.24m
AMGNAmgen, Inc. -0.49%255.001.3%$745.88m
GILDGilead Sciences, Inc. -0.19%76.621.0%$693.12m
REGNRegeneron Pharmaceuticals, Inc. 3.46%648.972.5%$685.20m
BIIBBiogen, Inc. 0.59%271.401.6%$581.49m
VRTXVertex Pharmaceuticals, Inc. 3.97%302.871.9%$531.71m
ILMNIllumina, Inc. -0.76%376.523.5%$302.41m
ALXNAlexion Pharmaceuticals, Inc. -0.50%113.002.0%$234.30m
BMRNBioMarin Pharmaceutical, Inc. 0.96%128.944.3%$219.55m
SGENSeattle Genetics, Inc. 4.61%178.306.1%$207.89m
SRNESorrento Therapeutics, Inc. 2.99%7.381.8%$197.64m
IMMUImmunomedics, Inc. 1.30%41.1611.0%$181.04m
SRPTSarepta Therapeutics, Inc. 1.73%166.3213.9%$174.11m
INCYIncyte Corp. 0.95%108.812.5%$165.88m

Company Profile

Actinium Pharmaceuticals, Inc. is a biopharmaceutical company. It is focused on developing Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation. Its product pipeline includes Iomab-B, Actimab-A, and Actimab-M. The company was founded in 1993 and is headquartered in New York, NY.